Teva buys Allergan Generics in $40bn deal

27-07-2015

Teva buys Allergan Generics in $40bn deal

Photo: Courtesy of Teva

Pharmaceutical company Teva has bought Allergan Generics from drugs business Allergan in a $40.5 billion deal.


Teva; Allergan; Allergan Generics; ANDA; generics; mergers and acquisitions; Erez Vigodman; Brent Saunders; FDA; Actavis

More on this story

Allergan sees off glaucoma patent challenges
05-08-2015

LSIPR